For patients with obstructive sleep apnea and cardiovascular disease, adherence seems to be the deciding factor for whether continuous positive airway pressure (CPAP) use is effective at secondary ...

Continuous positive airway pressure (CPAP) is the gold standard treatment for moderate-to-severe obstructive sleep apnea. But it may not be effective in adults aged 80 years and older, a new study ...

Telemonitoring may help improve continuous positive airway pressure (CPAP) therapy adherence for patients with obstructive sleep apnea syndrome (OSA), while motivational enhancement therapy (MET) most ...

Researchers found evidence for reduced risk of dying from all causes and cardiovascular disease when OSA patients were treated with CPAP versus non-CPAP users. Patients with obstructive sleep apnea ...

June 9 (UPI) A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study reports. Doctors favor treatment with continuous positive ...

For sleep apnea sufferers like Terri Domingo, using a breathing device isn’t just about getting a good night’s sleep. “I feel like this machine keeps me alive,” said Domingo, a health care worker in ...

WASHINGTON, Sept. 5, 2018 /PRNewswire/ -- A comprehensive report issued today by the American Sleep Apnea Association (ASAA) details the magnitude of human suffering, barriers to diagnosis and ...

In obstructive sleep apnea, using CPAP therapy more than 4 hours a night sharply cuts residual sleepiness and lowers crash ...

Please provide your email address to receive an email when new articles are posted on . Patients with COVID-19 respiratory failure using helmet CPAP vs. facemask CPAP had decreased intubation rates.

SEATTLE -- Weight loss drugs have gained momentum as treatment for obstructive sleep apnea (OSA) at sleep clinics across the country -- although patients appear more ready for the shift than the ...

Obese patients with type 2 diabetes are less likely to need a CPAP machine to treat sleep apnea if they’re taking a GLP-1 drug, researchers recently reported in JAMA Network Open. Patients were also ...